Test Overview: The Anti A Titre test measures the concentration (titre) of Anti-A antibodies present in the serum. It is primarily used in transfusion medicine and transplant settings to assess compatibility and reduce the risk of immune-mediated complications.
Why is this test done?
Evaluate ABO antibody levels before organ or stem cell transplantation.
Assess compatibility for ABO-incompatible transplants.
Support blood transfusion planning in selected clinical situations.
Monitor Anti-A antibody levels before and after treatment when indicated.
When is this test recommended?
Prior to ABO-incompatible kidney or liver transplantation.
Before hematopoietic stem cell transplantation.
During pre-transfusion compatibility assessment in specific cases.
As advised by a transplant physician or hematologist.
Preparation:
No fasting is required.
Inform your doctor about recent blood transfusions, immunotherapy, or plasma exchange procedures.
Interpretation:
Results are reported as an antibody titre (e.g., 1:8, 1:16, 1:64).
Higher titres indicate a greater concentration of Anti-A antibodies.
Interpretation should be performed by the treating physician in conjunction with clinical findings and transplant or transfusion requirements.
Who should get tested?
Patients undergoing ABO-incompatible organ transplantation.
Patients referred by transplant specialists or hematologists.
Note: Test results should always be interpreted by a qualified healthcare professional along with the patient's clinical history and other laboratory findings.